Argonautica Private Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.4M Sell
2,835
-91
-3% -$93K 0.83% 32
2026
Q1
$2.69M Sell
2,926
-73
-2% -$74K 0.81% 39
2025
Q4
$3.22M Sell
2,999
-53
-2% -$50.7K 0.95% 32
2025
Q3
$2.33M Sell
3,052
-43
-1% -$32K 0.68% 45
2025
Q2
$2.41M Sell
3,095
-113
-4% -$87.8K 0.76% 42
2025
Q1
$2.65M Buy
3,208
+16
+0.5% +$13.3K 0.91% 35
2024
Q4
$2.46M Buy
3,192
+13
+0.4% +$10.8K 0.8% 39
2024
Q3
$2.82M Buy
3,179
+49
+2% +$44.1K 0.93% 29
2024
Q2
$2.83M Buy
3,130
+361
+13% +$289K 0.97% 27
2024
Q1
$2.15M Buy
+2,769
New +$1.97M 0.77% 41

Other funds holding LLY

Argonautica Private Wealth Management's LLY Position: Q2 2026 in Review

Argonautica Private Wealth Management reduced its Eli Lilly (LLY) stake by 3.1% in Q2 2026, selling an estimated $93K and leaving 2,835 shares worth $3.4M. The position accounts for 0.83% of the portfolio, ranked #32.

Argonautica Private Wealth Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Argonautica Private Wealth Management held 2,835 shares of Eli Lilly worth $3.4M as of Q2 2026.
  • Argonautica Private Wealth Management sold 91 Eli Lilly shares in Q2 2026, an estimated $93K.
  • Eli Lilly made up 0.83% of Argonautica Private Wealth Management's portfolio in Q2 2026, its #32 holding.
  • Argonautica Private Wealth Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Argonautica Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.